Takeda Pharmaceutical (TAK) Stock Price, News & Analysis

Company Overview

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 143,897 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TAK Stock Analysis - Frequently Asked Questions

How do I buy shares of Takeda Pharmaceutical?

Shares of TAK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Takeda Pharmaceutical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Takeda Pharmaceutical investors own include Meta Platforms (META), Alibaba Group (BABA), Taiwan Semiconductor Manufacturing (TSM), JD.com (JD), Tesla (TSLA), Advanced Micro Devices (AMD) and JPMorgan Chase & Co. (JPM).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Manufacturing
• Industry: Medicinal & Botanical Manufacturing
• Sub-Industry: Pharmaceutical Products
• Current Symbol: CVE:TAK
• CIK: N/A
• Web: www.takugold.com
• Phone: +1-604-6420115
• Fax: N/A
• Employees: 47,300
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A